{"id":64406,"date":"2025-06-04T08:00:05","date_gmt":"2025-06-04T13:00:05","guid":{"rendered":"https:\/\/www.tradestation.com\/insights\/?p=64406"},"modified":"2025-06-04T08:26:39","modified_gmt":"2025-06-04T13:26:39","slug":"chart-biotechs-broken-downtrend","status":"publish","type":"post","link":"https:\/\/www.tradestation.com\/insights\/2025\/06\/04\/chart-biotechs-broken-downtrend\/","title":{"rendered":"Have Biotechs Broken Their Downtrend?"},"content":{"rendered":"

Biotechnology stocks have struggled this year along with the broader health-care sector, but some traders may think a bullish turn has begun.<\/p>\n

The first pattern on today\u2019s chart of the Nasdaq Biotechnology Index is the series of lower highs since early April. NBI closed above that falling trendline yesterday, which may signal …<\/p>\n

For more, please\u00a0click here<\/a>\u00a0to view the related idea and chart analysis on\u00a0TradingView<\/a>.<\/em><\/p>\n

\"\"

Nasdaq Biotechnology Index, daily chart, with selected patterns and indicators, courtesy of TradingView.<\/em><\/p><\/div>\n","protected":false},"excerpt":{"rendered":"

Biotechnology stocks have struggled this year along with the broader health-care sector, but some traders may think a bullish turn has begun.<\/p>\n","protected":false},"author":39,"featured_media":64412,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","inline_featured_image":false,"footnotes":""},"categories":[32,13,38],"tags":[],"class_list":["post-64406","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-healthcare","category-stocks","category-technical-analysis","et-has-post-format-content","et_post_format-et-post-format-standard"],"yoast_head":"\nHave Biotechs Broken Their Downtrend? | Market Insights<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.tradestation.com\/insights\/2025\/06\/04\/chart-biotechs-broken-downtrend\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Have Biotechs Broken Their Downtrend? | Market Insights\" \/>\n<meta property=\"og:description\" content=\"Biotechnology stocks have struggled this year along with the broader health-care sector, but some traders may think a bullish turn has begun.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.tradestation.com\/insights\/2025\/06\/04\/chart-biotechs-broken-downtrend\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Insights\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/TradeStation\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-06-04T13:00:05+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-06-04T13:26:39+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cdn.tradestation.com\/uploads\/sites\/2\/biotech_336473160_btt.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1080\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"David Russell\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@TradeStation\" \/>\n<meta name=\"twitter:site\" content=\"@TradeStation\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"David Russell\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.tradestation.com\/insights\/2025\/06\/04\/chart-biotechs-broken-downtrend\/\",\"url\":\"https:\/\/www.tradestation.com\/insights\/2025\/06\/04\/chart-biotechs-broken-downtrend\/\",\"name\":\"Have Biotechs Broken Their Downtrend? | Market Insights\",\"isPartOf\":{\"@id\":\"https:\/\/www.tradestation.com\/insights\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.tradestation.com\/insights\/2025\/06\/04\/chart-biotechs-broken-downtrend\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.tradestation.com\/insights\/2025\/06\/04\/chart-biotechs-broken-downtrend\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cdn.tradestation.com\/uploads\/sites\/2\/biotech_336473160_btt.jpg\",\"datePublished\":\"2025-06-04T13:00:05+00:00\",\"dateModified\":\"2025-06-04T13:26:39+00:00\",\"author\":{\"@id\":\"https:\/\/www.tradestation.com\/insights\/#\/schema\/person\/d2279ba57f90e3b47887f2503ce142d4\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.tradestation.com\/insights\/2025\/06\/04\/chart-biotechs-broken-downtrend\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.tradestation.com\/insights\/2025\/06\/04\/chart-biotechs-broken-downtrend\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.tradestation.com\/insights\/2025\/06\/04\/chart-biotechs-broken-downtrend\/#primaryimage\",\"url\":\"https:\/\/cdn.tradestation.com\/uploads\/sites\/2\/biotech_336473160_btt.jpg\",\"contentUrl\":\"https:\/\/cdn.tradestation.com\/uploads\/sites\/2\/biotech_336473160_btt.jpg\",\"width\":1920,\"height\":1080},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.tradestation.com\/insights\/2025\/06\/04\/chart-biotechs-broken-downtrend\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.tradestation.com\/insights\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Have Biotechs Broken Their Downtrend?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.tradestation.com\/insights\/#website\",\"url\":\"https:\/\/www.tradestation.com\/insights\/\",\"name\":\"Market Insights\",\"description\":\"Fresh market commentary and actionable trade ideas.\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.tradestation.com\/insights\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.tradestation.com\/insights\/#\/schema\/person\/d2279ba57f90e3b47887f2503ce142d4\",\"name\":\"David Russell\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.tradestation.com\/insights\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/443bdca82f0006231c5179581e4310ed?s=96&d=mm&r=pg\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/443bdca82f0006231c5179581e4310ed?s=96&d=mm&r=pg\",\"caption\":\"David Russell\"},\"description\":\"David Russell is Global Head of Market Strategy at TradeStation. Drawing on more than two decades of experience as a financial journalist and analyst, his background includes equities, emerging markets, fixed-income and derivatives. He previously worked at Bloomberg News, CNBC and E*TRADE Financial. Russell systematically reviews countless global financial headlines and indicators in search of broad tradable trends that present opportunities repeatedly over time. Customers can expect him to keep them apprised of sector leadership, relative strength and the big stories \u2013 especially those overlooked by other commentators. He\u2019s also a big fan of generating leverage with options to limit capital at risk.\",\"url\":\"https:\/\/www.tradestation.com\/insights\/author\/drussell\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Have Biotechs Broken Their Downtrend? | Market Insights","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.tradestation.com\/insights\/2025\/06\/04\/chart-biotechs-broken-downtrend\/","og_locale":"en_US","og_type":"article","og_title":"Have Biotechs Broken Their Downtrend? | Market Insights","og_description":"Biotechnology stocks have struggled this year along with the broader health-care sector, but some traders may think a bullish turn has begun.","og_url":"https:\/\/www.tradestation.com\/insights\/2025\/06\/04\/chart-biotechs-broken-downtrend\/","og_site_name":"Market Insights","article_publisher":"https:\/\/www.facebook.com\/TradeStation\/","article_published_time":"2025-06-04T13:00:05+00:00","article_modified_time":"2025-06-04T13:26:39+00:00","og_image":[{"width":1920,"height":1080,"url":"https:\/\/cdn.tradestation.com\/uploads\/sites\/2\/biotech_336473160_btt.jpg","type":"image\/jpeg"}],"author":"David Russell","twitter_card":"summary_large_image","twitter_creator":"@TradeStation","twitter_site":"@TradeStation","twitter_misc":{"Written by":"David Russell","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.tradestation.com\/insights\/2025\/06\/04\/chart-biotechs-broken-downtrend\/","url":"https:\/\/www.tradestation.com\/insights\/2025\/06\/04\/chart-biotechs-broken-downtrend\/","name":"Have Biotechs Broken Their Downtrend? | Market Insights","isPartOf":{"@id":"https:\/\/www.tradestation.com\/insights\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.tradestation.com\/insights\/2025\/06\/04\/chart-biotechs-broken-downtrend\/#primaryimage"},"image":{"@id":"https:\/\/www.tradestation.com\/insights\/2025\/06\/04\/chart-biotechs-broken-downtrend\/#primaryimage"},"thumbnailUrl":"https:\/\/cdn.tradestation.com\/uploads\/sites\/2\/biotech_336473160_btt.jpg","datePublished":"2025-06-04T13:00:05+00:00","dateModified":"2025-06-04T13:26:39+00:00","author":{"@id":"https:\/\/www.tradestation.com\/insights\/#\/schema\/person\/d2279ba57f90e3b47887f2503ce142d4"},"breadcrumb":{"@id":"https:\/\/www.tradestation.com\/insights\/2025\/06\/04\/chart-biotechs-broken-downtrend\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.tradestation.com\/insights\/2025\/06\/04\/chart-biotechs-broken-downtrend\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.tradestation.com\/insights\/2025\/06\/04\/chart-biotechs-broken-downtrend\/#primaryimage","url":"https:\/\/cdn.tradestation.com\/uploads\/sites\/2\/biotech_336473160_btt.jpg","contentUrl":"https:\/\/cdn.tradestation.com\/uploads\/sites\/2\/biotech_336473160_btt.jpg","width":1920,"height":1080},{"@type":"BreadcrumbList","@id":"https:\/\/www.tradestation.com\/insights\/2025\/06\/04\/chart-biotechs-broken-downtrend\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.tradestation.com\/insights\/"},{"@type":"ListItem","position":2,"name":"Have Biotechs Broken Their Downtrend?"}]},{"@type":"WebSite","@id":"https:\/\/www.tradestation.com\/insights\/#website","url":"https:\/\/www.tradestation.com\/insights\/","name":"Market Insights","description":"Fresh market commentary and actionable trade ideas.","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.tradestation.com\/insights\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.tradestation.com\/insights\/#\/schema\/person\/d2279ba57f90e3b47887f2503ce142d4","name":"David Russell","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.tradestation.com\/insights\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/443bdca82f0006231c5179581e4310ed?s=96&d=mm&r=pg","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/443bdca82f0006231c5179581e4310ed?s=96&d=mm&r=pg","caption":"David Russell"},"description":"David Russell is Global Head of Market Strategy at TradeStation. Drawing on more than two decades of experience as a financial journalist and analyst, his background includes equities, emerging markets, fixed-income and derivatives. He previously worked at Bloomberg News, CNBC and E*TRADE Financial. Russell systematically reviews countless global financial headlines and indicators in search of broad tradable trends that present opportunities repeatedly over time. Customers can expect him to keep them apprised of sector leadership, relative strength and the big stories \u2013 especially those overlooked by other commentators. He\u2019s also a big fan of generating leverage with options to limit capital at risk.","url":"https:\/\/www.tradestation.com\/insights\/author\/drussell\/"}]}},"_links":{"self":[{"href":"https:\/\/www.tradestation.com\/insights\/wp-json\/wp\/v2\/posts\/64406"}],"collection":[{"href":"https:\/\/www.tradestation.com\/insights\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.tradestation.com\/insights\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.tradestation.com\/insights\/wp-json\/wp\/v2\/users\/39"}],"replies":[{"embeddable":true,"href":"https:\/\/www.tradestation.com\/insights\/wp-json\/wp\/v2\/comments?post=64406"}],"version-history":[{"count":5,"href":"https:\/\/www.tradestation.com\/insights\/wp-json\/wp\/v2\/posts\/64406\/revisions"}],"predecessor-version":[{"id":64413,"href":"https:\/\/www.tradestation.com\/insights\/wp-json\/wp\/v2\/posts\/64406\/revisions\/64413"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.tradestation.com\/insights\/wp-json\/wp\/v2\/media\/64412"}],"wp:attachment":[{"href":"https:\/\/www.tradestation.com\/insights\/wp-json\/wp\/v2\/media?parent=64406"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.tradestation.com\/insights\/wp-json\/wp\/v2\/categories?post=64406"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.tradestation.com\/insights\/wp-json\/wp\/v2\/tags?post=64406"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}